GLUT1-mediated glucose flux constrains autoreactive but not foreign antigen-specific B-cell responses
The Journal of Immunology · 2026
DOI: 10.1093/jimmun/vkag092 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Yanan Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center, San Antonio, TX, United States. Hauptthemen laut MEDLINE: B-Lymphocytes, Glucose Transporter Type 1, Glucose, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health (NIH).
Abstract (Originalsprache)
Emerging evidence from lupus-prone mice and patients with systemic lupus erythematosus implicates enhanced glycolysis in lymphocytes as a driver of disease. We previously showed that the pharmacologic blockade of glycolysis reduced the production of autoantibodies without affecting antibodies induced by immunization to a foreign protein. Here we used CRISPR/Cas9 to reduce the expression of glucose transporter GLUT1 in B cells from autoreactive AM14 Vk8R (AM14) and antigen-specific B1-8 Jκ (B1-8) transgenic mice, comparing intrinsic glycolytic requirements across disease-relevant contexts. Following adoptive transfer into BALB/c recipients, Glut1 knockdown (Glut1KD) decreased the persistence of AM14 B cells, their differentiation into plasmablasts, and production of antibodies upon immunization with the PL2-3 hybridoma that activates both their B-cell receptor and endosomal TLR. In addition, PL2-3–stimulated Glut1KD AM14 B cells selectively reduced their CD80 expression both in vivo and in vitro, as well as ATP production and mammalian target of rapamycin (mTOR) signaling in vitro. In contrast, Glut1KD B1-8 B cells retained persistence, plasmablast output, and nitrophenyl (NP)–specific IgM production after NP-OVA immunization, with a selective reduction in the proliferation of naive B cells. Bioenergetic output was preserved despite Glut1KD in both clones stimulated with TLR7 agonist R848, but CD80 and mTOR signaling were differentially affected. Thus, GLUT1-dependent glycolysis is essential for immune complex–driven autoreactive B-cell activation yet largely dispensable for antigen-specific responses, identifying metabolic checkpoints that may selectively restrain pathogenic B cells while sparing protective humoral immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center, San Antonio, TX, United States.
- Program in Microbiology and Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
- Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
ORCID-Profile: Mark J Shlomchik
Förderung
- NIAID NIH HHS
- National Institutes of Health (NIH)
Zitieren
APA
Zhu, Y., Choi, S. C., Shlomchik, M. J., & Morel, L. (2026). GLUT1-mediated glucose flux constrains autoreactive but not foreign antigen-specific B-cell responses. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkag092
Vancouver
Zhu Y, Choi SC, Shlomchik MJ, Morel L. GLUT1-mediated glucose flux constrains autoreactive but not foreign antigen-specific B-cell responses. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkag092
BibTeX
@article{Zhu2026,
author = {Zhu, Yanan and Choi, Seung Chul and Shlomchik, Mark J and Morel, Laurence},
title = {GLUT1-mediated glucose flux constrains autoreactive but not foreign antigen-specific B-cell responses},
journal = {The Journal of Immunology},
year = {2026},
doi = {10.1093/jimmun/vkag092}
}
EUVIMED